Dashboard
Manage Tickers

AVXL


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jones-trading-downgrades-anavex-life-sciences-to-hold
Jones Trading Downgrades Anavex Life Scien...
10/24/2025 12:14:04

Jones Trading analyst Soumit Roy downgrades Anavex Life Sciences (NASDAQ:AVXL) from Buy to Hold.

anavex-highlights-oral-blarcamesines-patient-centric-alzheimers-care-at-alzheimer-europe-conference-via-prof-dr-timo-grimmers-phase-iibiii-study-presentation
Anavex Highlights Oral Blarcamesine's Pati...
10/10/2025 11:31:42

Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical compan...

hc-wainwright--co-reiterates-buy-on-anavex-life-sciences-maintains-42-price-target
HC Wainwright & Co. Reiterates Buy on Anav...
10/07/2025 10:47:39

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $4...

d-boral-capital-maintains-buy-on-anavex-life-sciences-maintains-46-price-target
D. Boral Capital Maintains Buy on Anavex L...
10/02/2025 14:37:19

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $46 price target.

anavex-life-sciences-announces-development-of-once-daily-oral-tablet-formulation-for-anavex-3-71-program
Anavex Life Sciences Announces Development...
10/02/2025 11:37:18

ANAVEX3-71-002 trial achieved its primary endpoint demonstrating safety and tolerability in both male and female adultsOral ANA...

anavex-schizophrenia-drug-shows-safety-results-in-phase-2-trial
Anavex Schizophrenia Drug Shows Safety Res...
10/02/2025 11:32:24

Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical compan...

d-boral-capital-maintains-buy-on-anavex-life-sciences-maintains-46-price-target
D. Boral Capital Maintains Buy on Anavex L...
10/01/2025 11:27:26

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $46 price target.

anavex-life-sciences-announces-publication-titled-oral-blarcamesine-phase-iibiii-trial-confirms-identified-precision-medicine-patient-population--significant-broad-clinical-and-quality-of-life-improvements-for-early-alzheimers-disease-patients
Anavex Life Sciences Announces Publication...
09/30/2025 12:31:28

hc-wainwright--co-reiterates-buy-on-anavex-life-sciences-maintains-42-price-target
HC Wainwright & Co. Reiterates Buy on Anav...
09/10/2025 16:45:29

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $4...

d-boral-capital-maintains-buy-on-anavex-life-sciences-maintains-46-price-target
D. Boral Capital Maintains Buy on Anavex L...
09/10/2025 11:31:09

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $46 price target.

anavex-life-sciences-highlights-new-clinical-precision-medicine-population-48-week-data
Anavex Life Sciences Highlights New Clinic...
09/09/2025 11:36:57

New clinical Precision Medicine population 48-week data demonstrates unprecedented cognitive stabilization in early Alzheimer&#...

d-boral-capital-maintains-buy-on-anavex-life-sciences-maintains-46-price-target
D. Boral Capital Maintains Buy on Anavex L...
08/27/2025 12:08:08

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $46 price target.

anavex-publishes-iscience-study-confirming-blarcamesine-restores-autophagy-via-sigma-1-receptor-supporting-alzheimers-therapy-potential
Anavex Publishes iScience Study Confirming...
08/26/2025 11:41:34

hc-wainwright--co-reiterates-buy-on-anavex-life-sciences-maintains-42-price-target
HC Wainwright & Co. Reiterates Buy on Anav...
08/22/2025 10:43:22

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $4...

anavex-life-pre-treatment-prevented-cognitive-impairment-in-animal-model-of-alzheimers-disease-new-publication-shows
Anavex Life Pre-Treatment Prevented Cognit...
08/20/2025 11:31:07

Anavex published data showing blarcamesine prevented amyloid-related brain damage in mice, supporting SIGMAR1 as a target for A...

anavex-life-sciences-peer--reviewed-publication-in-the-journal-neuroscience-letters-titled-prevention-of-memory-impairment-and-hippocampal-injury-with-blarcamesine-in-an-alzheimers-disease-model
Anavex Life Sciences Peer- Reviewed Public...
08/20/2025 11:29:55

anavex-life-sciences-says-this-study-shows-that-a-pre-treatment-with-blarcamesine-prevented-amyloid-beta-induced-memory-impairment-and-brain-oxidative-injury-suggesting-that--the-blarcamesine-is-an-attractive-candidate-for-alzheimers-disease pharmacological-prevention
Anavex Life Sciences Says 'This study show...
08/20/2025 11:29:48

d-boral-capital-maintains-buy-on-anavex-life-sciences-maintains-46-price-target
D. Boral Capital Maintains Buy on Anavex L...
08/13/2025 16:07:05

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $46 price target.

anavex-life-sciences-q3-eps-016-misses-014-estimate
Anavex Life Sciences Q3 EPS $(0.16) Misses...
08/12/2025 11:30:39

Anavex Life Sciences (NASDAQ:AVXL) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate o...

Core News & Articles
Earnings Scheduled For August 12, 2025
08/12/2025 08:32:28

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION